$OKLO

Hanson John sold $21K of OKLO

Hanson John (Chief of Staff) sold 539 shares of Oklo Inc. (OKLO) at $39.77 on 2026-08-24.

Original reporting
SEC EDGAR · Hanson John
Published Aug 25, 2026, 8:09 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 25, 2026, 8:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$OKLO
Neutral
medium confidence
Mentioned
$OKLO
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OKLONeutralLow
01

Why it matters

The disclosed sale is modest and unlikely to affect OKLO's stock price materially.

02

Market read

Minor insider transaction with limited trading relevance.

03

What to watch

Insider retains >99% of prior holdings, indicating continued confidence.

Relevance 3/10Novelty 4/10Timing: reported after market close on 2026-08-24

Background

Form 4 filings provide the first public disclosure of insider transactions.

Company-level read

Ticker impact

$OKLONeutralMedium confidence
Context

Form 4 disclosed Chief of Staff Hanson John sold 539 shares of OKLO for $21,436, reducing his stake to 359,430 shares.

Expected impact

minimal impact, possible slight downward pressure

Evidence & confidence

Sale amount is small relative to market cap and insider still holds a large position.

Market effects

No broader sector impact; OKLO operates in nuclear energy niche.

Limited to US investors tracking insider activity.

Low global relevance.

Counterpoint

The sale could be a routine portfolio rebalancing, not a negative signal.

Key entities

  • Oklo Inc.

    US-listed nuclear energy company (ticker OKLO).

  • Hanson John

    Chief of Staff at Oklo, reporting insider sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SMRLowAI 8/10

NuScale Power Falls 7% as 10-Year Treasury Yield Climbs to 5.26%; Energy Fuels Drops 9%, Oklo Slides 5%

NuScale Power (SMR) fell 7% to $6.04, Energy Fuels (UUUU) dropped 9% to $8.43, and Oklo (OKLO) slid 5% to $30.11 as 10-year Treasury yields rose to 5.26%. The Global X Uranium ETF (URA) declined 4%, outpacing the broader market's 0.8% drop. Rising yields impact long-duration assets like nuclear developers, affecting both valuation and project financing costs.

$OKLOHigh

Oklo Launched Another $1 Billion Stock Sale. Here's How Much Dilution Shareholders Have Absorbed Since It Went Public.

Oklo (NYSE: OKLO), a nuclear energy company, launched a $1 billion stock sale on Sept. 11, adding to prior sales since its May 2024 SPAC merger. Outstanding shares increased 58% to 192.3 million, diluting early shareholders by 37%. Despite a 311% share price increase, Oklo's stock hit a 52-week low on Oct. 8, requiring more shares to raise the same capital.

$GOOGHighAI 8/10

Google Signed a Deal for Existing Reactors. So Why Did Oklo and NuScale Jump on the Constellation Energy News? The Read-Through Investors Are Missing.

Alphabet (GOOG, GOOGL) agreed to a 15-year and 20-year deal with Constellation Energy (CEG) for nuclear power, investing $4.3B in new capacity. Oklo (OKLO) and NuScale (SMR) shares also rose, despite no direct involvement. The companies develop small modular reactors (SMRs) for specific facilities, differing from Constellation's large-scale plants. Investors see broader nuclear energy growth, with SMRs expected to play a significant role by 2050, according to industry estimates.

$OKLOMed

Oklo (OKLO) Dropped, So What Is Driving Attention Now?

Oklo, a modular nuclear reactor company, focuses on selling long-term electricity contracts. It secured NRC approval for its Aurora design, has $1.6B cash, and partnerships with NVDA, META, and Switch. However, it reports $33M net loss, no revenue, and no operating plants. Market cap is $11B. Regulatory hurdles remain.

$OKLOMed

Oklo selected for DOE isotope production initiative

Oklo Inc. (NYSE:OKLO) was chosen by the U.S. Department of Energy to advance its Groves 2 Forge facility, focusing on producing lutetium-177 for cancer treatments. The project is part of the DOE’s initiative to boost domestic nuclear reactor development and isotope production. Oklo aims to transition from pilot to commercial-scale operations with regulatory approvals.